A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

This study is currently recruiting participants.
Verified August 2011 by Fondazione Giovanni Pascale
Sponsor:
Information provided by:
Fondazione Giovanni Pascale
ClinicalTrials.gov Identifier:
NCT01412307
First received: August 3, 2011
Last updated: August 8, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)